Correlation of Tim-3 expression with chemokine levels for predicting the prognosis of patients with glioblastoma

Zhengquan Zhu,Xiangheng Zhang,Zepeng Yu,Yi Zhou,Sihan Zhu,Yi Hong Zhang,Xiao Ping Lin,Yonggao Mou,Ji Zhang,Yi hong Zhang,Xiao ping Lin
DOI: https://doi.org/10.1016/j.jneuroim.2021.577575
IF: 3.221
2021-06-01
Journal of Neuroimmunology
Abstract:<p>Glioblastoma (GBM) immunotherapy, which blocks the checkpoint inhibitor molecule T cell immunoglobulin domain and mucin domain-3 (Tim-3), has potential therapeutic applications. However, not all patients do benefit from the targeted therapy. This study aimed to explore Tim-3 expression correlated chemokine profiles and immune cell infiltration and investigate their potential as prognostic markers of glioblastoma (GBM) immunotherapy. We analyzed transcriptional data of GBM from TCGA database, to measure Tim-3 expression by R package DESeq2 analysis and observed differentially expressed genes in GBM samples with high Tim-3 expression levels. We also probed the relative gene enrichment pathways. Tim-3 expression was evident in biological processes including the recruitment of immune cells. We also identified some chemokines related to Tim-3 expression. The expression levels of CCL18, CXCL13 and CCL7 were significantly higher in GBM tissues with high Tim-3 expression than in GBM tissues with low Tim-3 expression. In addition, exploring the relationship between immune cell infiltration and Tim-3 expression suggested that Tim-3 expression was positively related to significant immune cell infiltration.</p>
immunology,neurosciences
What problem does this paper attempt to address?